Related Experiment Videos
Current management of sacral chordoma
Daryl R Fourney1, Ziya L Gokaslan
1Division of Neurosurgery, Royal University Hospital, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Neurosurgical Focus
|September 8, 2004
Summary
Sacral chordomas, rare malignant tumors, have a poor prognosis mainly due to incomplete surgical resection. Improved surgical techniques offer better outcomes for these challenging sacral tumors.
Area of Science:
- Oncology
- Surgical Oncology
- Neurosurgery
Background:
- Sacral chordomas are rare, locally invasive malignant neoplasms.
- Prognosis is often poor, primarily due to challenges in achieving complete surgical resection.
- Metastasis is infrequent at initial presentation.
Purpose of the Study:
- To review the clinical presentation and natural history of sacral chordoma.
- To discuss current treatment techniques and outcomes for sacral chordoma.
- To highlight advancements in surgical resection for sacral chordoma.
Main Methods:
- Review of clinical presentation and natural history.
- Discussion of current surgical techniques, including en bloc resection.
- Analysis of treatment outcomes and functional costs.
Main Results:
- Complete resection of sacral chordomas is challenging but achievable with improved techniques.
- En bloc sacral resections with wide margins are increasingly feasible.
- High sacral level involvement increases technical difficulty and functional deficits (anorectal, urogenital).
Conclusions:
- Resection remains the primary treatment for sacral chordoma.
- Adjuvant treatment efficacy is uncertain.
- Advancements in imaging and surgical techniques improve the potential for complete tumor removal and patient outcomes.